News & Press: Press

ISCT Featured in The Wall Street Journal

Monday, August 28, 2017  
Share |

 

ISCT leader Bill Milligan, Chair of the Business Models and Cost of Goods Subcommittee speaks on behalf of ISCT to the Wall Street Journal.

August 28 - The Promising New Cancer Treatment Behind Gilead's $11 Billion Deal. Read the Article


© 2018 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered service marks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.